Clinical Trial Update: Centralized Pan-Asian Survey on the Under Treatment of Hypercholesterolemia

View source ↗

Summary

A completed centralized Pan-Asian survey sponsored by AstraZeneca assessing under-treatment of hypercholesterolemia. The study gathers observational data rather…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Snippet

Sponsor: AstraZeneca | Conditions: Hypercholesterolemia | Status: COMPLETED